Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.

The market is mainly driven by the significant applications of Imatinib Drug in various end use industries. The expanding demands from the Chronic Myelogenous Leukemia, Gastrointestinal Stromal Tumors and Others,, are propelling Imatinib Drug market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Imatinib Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Imatinib Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Imatinib Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Imatinib Drug sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Imatinib Drug covered in this report include Novartis, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Cipla Inc. and Apotex Inc., etc.

The global Imatinib Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Novartis

Glenmark Pharmaceuticals Ltd.

Sun Pharmaceuticals

Actavis Generics

Dr. Reddy's Laboratories

Teva Pharmaceutical Industries Ltd.

Sanofi S.A.

Cipla Inc.

Apotex Inc.

Mylan Pharms Inc.

Scope of Imatinib Drug - Market Report

Report Metric	Details
Report Name	Imatinib Drug - Market
Forecasted market size in 2029	US$ 3621.8 million
CAGR	3.8%
Forecasted years	2023 - 2029
Global Imatinib Drug market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Imatinib Drug market, Segment by Type:	Tablets Capsules
Global Imatinib Drug market, by Application	Chronic Myelogenous Leukemia Gastrointestinal Stromal Tumors Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Imatinib Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Imatinib Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Imatinib Drug - Market size in 2029?

Ans: The Imatinib Drug - Market size in 2029 will be US$ 3621.8 million.

What are the Application segmentation covered in the Imatinib Drug - Market report?

Ans: The Applications covered in the Imatinib Drug - Market report are Chronic Myelogenous Leukemia, Gastrointestinal Stromal Tumors, Others

What are the Type segmentation covered in the Imatinib Drug - Market report?

Ans: The Types covered in the Imatinib Drug - Market report are Tablets, Capsules

1 Imatinib Drug Market Overview

1.1 Imatinib Drug Product Overview

1.2 Imatinib Drug Market Segment by Type

1.2.1 Tablets

1.2.2 Capsules

1.3 Global Imatinib Drug Market Size by Type

1.3.1 Global Imatinib Drug Market Size Overview by Type (2018-2029)

1.3.2 Global Imatinib Drug Historic Market Size Review by Type (2018-2023)

1.3.3 Global Imatinib Drug Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Imatinib Drug Sales Breakdown by Type (2018-2023)

1.4.2 Europe Imatinib Drug Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Imatinib Drug Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Imatinib Drug Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Imatinib Drug Sales Breakdown by Type (2018-2023)

2 Global Imatinib Drug Market Competition by Company

2.1 Global Top Players by Imatinib Drug Sales (2018-2023)

2.2 Global Top Players by Imatinib Drug Revenue (2018-2023)

2.3 Global Top Players by Imatinib Drug Price (2018-2023)

2.4 Global Top Manufacturers Imatinib Drug Manufacturing Base Distribution, Sales Area, Product Type

2.5 Imatinib Drug Market Competitive Situation and Trends

2.5.1 Imatinib Drug Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Imatinib Drug Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Drug as of 2022)

2.7 Date of Key Manufacturers Enter into Imatinib Drug Market

2.8 Key Manufacturers Imatinib Drug Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Imatinib Drug Status and Outlook by Region

3.1 Global Imatinib Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Imatinib Drug Historic Market Size by Region

3.2.1 Global Imatinib Drug Sales in Volume by Region (2018-2023)

3.2.2 Global Imatinib Drug Sales in Value by Region (2018-2023)

3.2.3 Global Imatinib Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Imatinib Drug Forecasted Market Size by Region

3.3.1 Global Imatinib Drug Sales in Volume by Region (2024-2029)

3.3.2 Global Imatinib Drug Sales in Value by Region (2024-2029)

3.3.3 Global Imatinib Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Imatinib Drug by Application

4.1 Imatinib Drug Market Segment by Application

4.1.1 Chronic Myelogenous Leukemia

4.1.2 Gastrointestinal Stromal Tumors

4.1.3 Others

4.2 Global Imatinib Drug Market Size by Application

4.2.1 Global Imatinib Drug Market Size Overview by Application (2018-2029)

4.2.2 Global Imatinib Drug Historic Market Size Review by Application (2018-2023)

4.2.3 Global Imatinib Drug Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Imatinib Drug Sales Breakdown by Application (2018-2023)

4.3.2 Europe Imatinib Drug Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Imatinib Drug Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Imatinib Drug Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Imatinib Drug Sales Breakdown by Application (2018-2023)

5 North America Imatinib Drug by Country

5.1 North America Imatinib Drug Historic Market Size by Country

5.1.1 North America Imatinib Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Imatinib Drug Sales in Volume by Country (2018-2023)

5.1.3 North America Imatinib Drug Sales in Value by Country (2018-2023)

5.2 North America Imatinib Drug Forecasted Market Size by Country

5.2.1 North America Imatinib Drug Sales in Volume by Country (2024-2029)

5.2.2 North America Imatinib Drug Sales in Value by Country (2024-2029)

6 Europe Imatinib Drug by Country

6.1 Europe Imatinib Drug Historic Market Size by Country

6.1.1 Europe Imatinib Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Imatinib Drug Sales in Volume by Country (2018-2023)

6.1.3 Europe Imatinib Drug Sales in Value by Country (2018-2023)

6.2 Europe Imatinib Drug Forecasted Market Size by Country

6.2.1 Europe Imatinib Drug Sales in Volume by Country (2024-2029)

6.2.2 Europe Imatinib Drug Sales in Value by Country (2024-2029)

7 Asia-Pacific Imatinib Drug by Region

7.1 Asia-Pacific Imatinib Drug Historic Market Size by Region

7.1.1 Asia-Pacific Imatinib Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Imatinib Drug Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Imatinib Drug Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Imatinib Drug Forecasted Market Size by Region

7.2.1 Asia-Pacific Imatinib Drug Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Imatinib Drug Sales in Value by Region (2024-2029)

8 Latin America Imatinib Drug by Country

8.1 Latin America Imatinib Drug Historic Market Size by Country

8.1.1 Latin America Imatinib Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Imatinib Drug Sales in Volume by Country (2018-2023)

8.1.3 Latin America Imatinib Drug Sales in Value by Country (2018-2023)

8.2 Latin America Imatinib Drug Forecasted Market Size by Country

8.2.1 Latin America Imatinib Drug Sales in Volume by Country (2024-2029)

8.2.2 Latin America Imatinib Drug Sales in Value by Country (2024-2029)

9 Middle East and Africa Imatinib Drug by Country

9.1 Middle East and Africa Imatinib Drug Historic Market Size by Country

9.1.1 Middle East and Africa Imatinib Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Imatinib Drug Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Imatinib Drug Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Imatinib Drug Forecasted Market Size by Country

9.2.1 Middle East and Africa Imatinib Drug Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Imatinib Drug Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Novartis

10.1.1 Novartis Company Information

10.1.2 Novartis Introduction and Business Overview

10.1.3 Novartis Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Novartis Imatinib Drug Products Offered

10.1.5 Novartis Recent Development

10.2 Glenmark Pharmaceuticals Ltd.

10.2.1 Glenmark Pharmaceuticals Ltd. Company Information

10.2.2 Glenmark Pharmaceuticals Ltd. Introduction and Business Overview

10.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Products Offered

10.2.5 Glenmark Pharmaceuticals Ltd. Recent Development

10.3 Sun Pharmaceuticals

10.3.1 Sun Pharmaceuticals Company Information

10.3.2 Sun Pharmaceuticals Introduction and Business Overview

10.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Sun Pharmaceuticals Imatinib Drug Products Offered

10.3.5 Sun Pharmaceuticals Recent Development

10.4 Actavis Generics

10.4.1 Actavis Generics Company Information

10.4.2 Actavis Generics Introduction and Business Overview

10.4.3 Actavis Generics Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Actavis Generics Imatinib Drug Products Offered

10.4.5 Actavis Generics Recent Development

10.5 Dr. Reddy's Laboratories

10.5.1 Dr. Reddy's Laboratories Company Information

10.5.2 Dr. Reddy's Laboratories Introduction and Business Overview

10.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Dr. Reddy's Laboratories Imatinib Drug Products Offered

10.5.5 Dr. Reddy's Laboratories Recent Development

10.6 Teva Pharmaceutical Industries Ltd.

10.6.1 Teva Pharmaceutical Industries Ltd. Company Information

10.6.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview

10.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Products Offered

10.6.5 Teva Pharmaceutical Industries Ltd. Recent Development

10.7 Sanofi S.A.

10.7.1 Sanofi S.A. Company Information

10.7.2 Sanofi S.A. Introduction and Business Overview

10.7.3 Sanofi S.A. Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Sanofi S.A. Imatinib Drug Products Offered

10.7.5 Sanofi S.A. Recent Development

10.8 Cipla Inc.

10.8.1 Cipla Inc. Company Information

10.8.2 Cipla Inc. Introduction and Business Overview

10.8.3 Cipla Inc. Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Cipla Inc. Imatinib Drug Products Offered

10.8.5 Cipla Inc. Recent Development

10.9 Apotex Inc.

10.9.1 Apotex Inc. Company Information

10.9.2 Apotex Inc. Introduction and Business Overview

10.9.3 Apotex Inc. Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Apotex Inc. Imatinib Drug Products Offered

10.9.5 Apotex Inc. Recent Development

10.10 Mylan Pharms Inc.

10.10.1 Mylan Pharms Inc. Company Information

10.10.2 Mylan Pharms Inc. Introduction and Business Overview

10.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Mylan Pharms Inc. Imatinib Drug Products Offered

10.10.5 Mylan Pharms Inc. Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Imatinib Drug Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Imatinib Drug Industrial Chain Analysis

11.4 Imatinib Drug Market Dynamics

11.4.1 Imatinib Drug Industry Trends

11.4.2 Imatinib Drug Market Drivers

11.4.3 Imatinib Drug Market Challenges

11.4.4 Imatinib Drug Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Imatinib Drug Distributors

12.3 Imatinib Drug Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Novartis

Glenmark Pharmaceuticals Ltd

Sun Pharmaceuticals

Actavis Generics

Dr. Reddy’s Laboratories

Teva Pharmaceutical Industries Ltd

List of Tables

Table 1. Major Company of Tablets

Table 2. Major Company of Capsules

Table 3. Global Imatinib Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 4. Global Imatinib Drug Sales by Type (2018-2023) & (K Units)

Table 5. Global Imatinib Drug Sales Market Share in Volume by Type (2018-2023)

Table 6. Global Imatinib Drug Sales by Type (2018-2023) & (US& Million)

Table 7. Global Imatinib Drug Market Share in Value by Type (2018-2023)

Table 8. Global Imatinib Drug Price by Type (2018-2023) & (USD/Unit)

Table 9. Global Imatinib Drug Sales by Type (2024-2029) & (K Units)

Table 10. Global Imatinib Drug Sales Market Share in Volume by Type (2024-2029)

Table 11. Global Imatinib Drug Sales by Type (2024-2029) & (US$ Million)

Table 12. Global Imatinib Drug Sales Market Share in Value by Type (2024-2029)

Table 13. Global Imatinib Drug Price by Type (2024-2029) & (USD/Unit)

Table 14. North America Imatinib Drug Sales by Type (2018-2023) & (K Units)

Table 15. North America Imatinib Drug Sales by Type (2018-2023) & (US$ Million)

Table 16. Europe Imatinib Drug Sales (K Units) by Type (2018-2023)

Table 17. Europe Imatinib Drug Sales by Type (2018-2023) & (US$ Million)

Table 18. Asia-Pacific Imatinib Drug Sales (K Units) by Type (2018-2023)

Table 19. Asia-Pacific Imatinib Drug Sales by Type (2018-2023) & (US$ Million)

Table 20. Latin America Imatinib Drug Sales (K Units) by Type (2018-2023)

Table 21. Latin America Imatinib Drug Sales by Type (2018-2023) & (US$ Million)

Table 22. Middle East and Africa Imatinib Drug Sales (K Units) by Type (2018-2023)

Table 23. Middle East and Africa Imatinib Drug Sales by Type (2018-2023) & (US$ Million)

Table 24. Global Imatinib Drug Sales by Company (2018-2023) & (K Units)

Table 25. Global Imatinib Drug Sales Share by Company (2018-2023)

Table 26. Global Imatinib Drug Revenue by Company (2018-2023) & (US$ Million)

Table 27. Global Imatinib Drug Revenue Share by Company (2018-2023)

Table 28. Global Market Imatinib Drug Price by Company (2018-2023) & (USD/Unit)

Table 29. Global Imatinib Drug Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 30. Global Imatinib Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Drug as of 2022)

Table 32. Date of Key Manufacturers Enter into Imatinib Drug Market

Table 33. Key Manufacturers Imatinib Drug Product Type

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global Imatinib Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 36. Global Imatinib Drug Sales by Region (2018-2023) & (K Units)

Table 37. Global Imatinib Drug Sales Market Share in Volume by Region (2018-2023)

Table 38. Global Imatinib Drug Sales by Region (2018-2023) & (US$ Million)

Table 39. Global Imatinib Drug Sales Market Share in Value by Region (2018-2023)

Table 40. Global Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 41. Global Imatinib Drug Sales by Region (2024-2029) & (K Units)

Table 42. Global Imatinib Drug Sales Market Share in Volume by Region (2024-2029)

Table 43. Global Imatinib Drug Sales by Region (2024-2029) & (US$ Million)

Table 44. Global Imatinib Drug Sales Market Share in Value by Region (2024-2029)

Table 45. Global Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)

Table 46. Global Imatinib Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 47. Global Imatinib Drug Sales by Application (2018-2023) & (K Units)

Table 48. Global Imatinib Drug Sales Market Share in Volume by Application (2018-2023)

Table 49. Global Imatinib Drug Sales by Application (2018-2023) & (US$ Million)

Table 50. Global Imatinib Drug Sales Market Share in Value by Application (2018-2023)

Table 51. Global Imatinib Drug Price by Application (2018-2023) & (USD/Unit)

Table 52. Global Imatinib Drug Sales by Application (2024-2029) & (K Units)

Table 53. Global Imatinib Drug Sales Market Share in Volume by Application (2024-2029)

Table 54. Global Imatinib Drug Sales by Application (2024-2029) & (US$ Million)

Table 55. Global Imatinib Drug Sales Market Share in Value by Application (2024-2029)

Table 56. Global Imatinib Drug Price by Application (2024-2029) & (USD/Unit)

Table 57. North America Imatinib Drug Sales by Application (2018-2023) (K Units)

Table 58. North America Imatinib Drug Sales by Application (2018-2023) & (US$ Million)

Table 59. Europe Imatinib Drug Sales by Application (2018-2023) (K Units)

Table 60. Europe Imatinib Drug Sales by Application (2018-2023) & (US$ Million)

Table 61. Asia-Pacific Imatinib Drug Sales by Application (2018-2023) (K Units)

Table 62. Asia-Pacific Imatinib Drug Sales by Application (2018-2023) & (US$ Million)

Table 63. Latin America Imatinib Drug Sales by Application (2018-2023) (K Units)

Table 64. Latin America Imatinib Drug Sales by Application (2018-2023) & (US$ Million)

Table 65. Middle East and Africa Imatinib Drug Sales by Application (2018-2023) (K Units)

Table 66. Middle East and Africa Imatinib Drug Sales by Application (2018-2023) & (US$ Million)

Table 67. North America Imatinib Drug Sales by Country (2018-2023) & (K Units)

Table 68. North America Imatinib Drug Sales Market Share in Volume by Country (2018-2023)

Table 69. North America Imatinib Drug Sales by Country (2018-2023) & (US$ Million)

Table 70. North America Imatinib Drug Sales Market Share in Value by Country (2018-2023)

Table 71. North America Imatinib Drug Sales by Country (2024-2029) & (K Units)

Table 72. North America Imatinib Drug Sales Market Share in Volume by Country (2024-2029)

Table 73. North America Imatinib Drug Sales by Country (2024-2029) & (US$ Million)

Table 74. North America Imatinib Drug Sales Market Share in Value by Country (2024-2029)

Table 75. Europe Imatinib Drug Sales by Country (2018-2023) & (K Units)

Table 76. Europe Imatinib Drug Sales Market Share in Volume by Country (2018-2023)

Table 77. Europe Imatinib Drug Sales by Country (2018-2023) & (US$ Million)

Table 78. Europe Imatinib Drug Sales Market Share in Value by Country (2018-2023)

Table 79. Europe Imatinib Drug Sales by Country (2024-2029) & (K Units)

Table 80. Europe Imatinib Drug Sales Market Share in Volume by Country (2024-2029)

Table 81. Europe Imatinib Drug Sales by Country (2024-2029) & (US$ Million)

Table 82. Europe Imatinib Drug Sales Market Share in Value by Country (2024-2029)

Table 83. Asia-Pacific Imatinib Drug Sales by Region (2018-2023) & (K Units)

Table 84. Asia-Pacific Imatinib Drug Sales Market Share in Volume by Region (2018-2023)

Table 85. Asia-Pacific Imatinib Drug Sales by Region (2018-2023) & (US$ Million)

Table 86. Asia-Pacific Imatinib Drug Sales Market Share in Value by Region (2018-2023)

Table 87. Asia-Pacific Imatinib Drug Sales by Region (2024-2029) & (K Units)

Table 88. Asia-Pacific Imatinib Drug Sales Market Share in Volume by Region (2024-2029)

Table 89. Asia-Pacific Imatinib Drug Sales by Region (2024-2029) & (US$ Million)

Table 90. Asia-Pacific Imatinib Drug Sales Market Share in Value by Region (2024-2029)

Table 91. Latin America Imatinib Drug Sales by Country (2018-2023) & (K Units)

Table 92. Latin America Imatinib Drug Sales Market Share in Volume by Country (2018-2023)

Table 93. Latin America Imatinib Drug Sales by Country (2018-2023) & (US$ Million)

Table 94. Latin America Imatinib Drug Sales Market Share in Value by Country (2018-2023)

Table 95. Latin America Imatinib Drug Sales by Country (2024-2029) & (K Units)

Table 96. Latin America Imatinib Drug Sales Market Share in Volume by Country (2024-2029)

Table 97. Latin America Imatinib Drug Sales by Country (2024-2029) & (US$ Million)

Table 98. Latin America Imatinib Drug Sales Market Share in Value by Country (2024-2029)

Table 99. Middle East and Africa Imatinib Drug Sales by Country (2018-2023) & (K Units)

Table 100. Middle East and Africa Imatinib Drug Sales Market Share in Volume by Country (2018-2023)

Table 101. Middle East and Africa Imatinib Drug Sales by Country (2018-2023) & (US$ Million)

Table 102. Middle East and Africa Imatinib Drug Sales Market Share in Value by Country (2018-2023)

Table 103. Middle East and Africa Imatinib Drug Sales by Country (2024-2029) & (K Units)

Table 104. Middle East and Africa Imatinib Drug Sales Market Share in Volume by Country (2024-2029)

Table 105. Middle East and Africa Imatinib Drug Sales by Country (2024-2029) & (US$ Million)

Table 106. Middle East and Africa Imatinib Drug Sales Market Share in Value by Country (2024-2029)

Table 107. Novartis Company Information

Table 108. Novartis Introduction and Business Overview

Table 109. Novartis Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 110. Novartis Imatinib Drug Product

Table 111. Novartis Recent Development

Table 112. Glenmark Pharmaceuticals Ltd. Company Information

Table 113. Glenmark Pharmaceuticals Ltd. Introduction and Business Overview

Table 114. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 115. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product

Table 116. Glenmark Pharmaceuticals Ltd. Recent Development

Table 117. Sun Pharmaceuticals Company Information

Table 118. Sun Pharmaceuticals Introduction and Business Overview

Table 119. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 120. Sun Pharmaceuticals Imatinib Drug Product

Table 121. Sun Pharmaceuticals Recent Development

Table 122. Actavis Generics Company Information

Table 123. Actavis Generics Introduction and Business Overview

Table 124. Actavis Generics Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 125. Actavis Generics Imatinib Drug Product

Table 126. Actavis Generics Recent Development

Table 127. Dr. Reddy's Laboratories Company Information

Table 128. Dr. Reddy's Laboratories Introduction and Business Overview

Table 129. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 130. Dr. Reddy's Laboratories Imatinib Drug Product

Table 131. Dr. Reddy's Laboratories Recent Development

Table 132. Teva Pharmaceutical Industries Ltd. Company Information

Table 133. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview

Table 134. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 135. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product

Table 136. Teva Pharmaceutical Industries Ltd. Recent Development

Table 137. Sanofi S.A. Company Information

Table 138. Sanofi S.A. Introduction and Business Overview

Table 139. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 140. Sanofi S.A. Imatinib Drug Product

Table 141. Sanofi S.A. Recent Development

Table 142. Cipla Inc. Company Information

Table 143. Cipla Inc. Introduction and Business Overview

Table 144. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 145. Cipla Inc. Imatinib Drug Product

Table 146. Cipla Inc. Recent Development

Table 147. Apotex Inc. Company Information

Table 148. Apotex Inc. Introduction and Business Overview

Table 149. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 150. Apotex Inc. Imatinib Drug Product

Table 151. Apotex Inc. Recent Development

Table 152. Mylan Pharms Inc. Company Information

Table 153. Mylan Pharms Inc. Introduction and Business Overview

Table 154. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 155. Mylan Pharms Inc. Imatinib Drug Product

Table 156. Mylan Pharms Inc. Recent Development

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Imatinib Drug Market Trends

Table 160. Imatinib Drug Market Drivers

Table 161. Imatinib Drug Market Challenges

Table 162. Imatinib Drug Market Restraints

Table 163. Imatinib Drug Distributors List

Table 164. Imatinib Drug Downstream Customers

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

List of Figures

Figure 1. Imatinib Drug Product Picture

Figure 2. Global Imatinib Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Imatinib Drug Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Imatinib Drug Sales Status and Outlook (2018-2029) & (K Units)

Figure 5. Product Picture of Tablets

Figure 6. Global Tablets Sales YoY Growth (2018-2029) & (K Units)

Figure 7. Product Picture of Capsules

Figure 8. Global Capsules Sales YoY Growth (2018-2029) & (K Units)

Figure 9. Global Imatinib Drug Sales by Type (2018-2029) & (US$ Million)

Figure 10. Global Imatinib Drug Sales Market Share by Type in 2022 & 2029

Figure 11. North America Imatinib Drug Sales Market Share in Volume by Type in 2022

Figure 12. North America Imatinib Drug Sales Market Share in Value by Type in 2022

Figure 13. Europe Imatinib Drug Sales Market Share in Volume by Type in 2022

Figure 14. Europe Imatinib Drug Sales Market Share in Value by Type in 2022

Figure 15. Asia-Pacific Imatinib Drug Sales Market Share in Volume by Type in 2022

Figure 16. Asia-Pacific Imatinib Drug Sales Market Share in Value by Type in 2022

Figure 17. Latin America Imatinib Drug Sales Market Share in Volume by Type in 2022

Figure 18. Latin America Imatinib Drug Sales Market Share in Value by Type in 2022

Figure 19. Middle East and Africa Imatinib Drug Sales Market Share in Volume by Type in 2022

Figure 20. Middle East and Africa Imatinib Drug Sales Market Share in Value by Type in 2022

Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Drug Sales in 2022

Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Drug Revenue in 2022

Figure 23. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 24. Product Picture of Chronic Myelogenous Leukemia

Figure 25. Global Chronic Myelogenous Leukemia Sales YoY Growth (2018-2029) & (K Units)

Figure 26. Product Picture of Gastrointestinal Stromal Tumors

Figure 27. Global Gastrointestinal Stromal Tumors Sales YoY Growth (2018-2029) & (K Units)

Figure 28. Product Picture of Others

Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units)

Figure 30. Global Imatinib Drug Sales by Application (2018-2029) & (US$ Million)

Figure 31. Global Imatinib Drug Sales Market Share by Application in 2022 & 2029

Figure 32. North America Imatinib Drug Sales Market Share in Volume by Application in 2022

Figure 33. North America Imatinib Drug Sales Market Share in Value by Application in 2022

Figure 34. Europe Imatinib Drug Sales Market Share in Volume by Application in 2022

Figure 35. Europe Imatinib Drug Sales Market Share in Value by Application in 2022

Figure 36. Asia-Pacific Imatinib Drug Sales Market Share in Volume by Application in 2022

Figure 37. Asia-Pacific Imatinib Drug Sales Market Share in Value by Application in 2022

Figure 38. Latin America Imatinib Drug Sales Market Share in Volume by Application in 2022

Figure 39. Latin America Imatinib Drug Sales Market Share in Value by Application in 2022

Figure 40. Middle East and Africa Imatinib Drug Sales Market Share in Value by Application in 2022

Figure 41. Key Raw Materials Price

Figure 42. Imatinib Drug Manufacturing Cost Structure

Figure 43. Imatinib Drug Industrial Chain Analysis

Figure 44. Channels of Distribution

Figure 45. Distributors Profiles

Figure 46. Bottom-up and Top-down Approaches for This Report

Figure 47. Data Triangulation

Figure 48. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions